![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Dr. Claus Feussner
Dr. Claus Feussner is Senior Vice President of Vetter Development Service, responsible for the company’s development centers in Ravensburg, Rankweil, and Chicago. Vetter is an independent international contract development and manufacturing organization (CDMO), headquartered in Ravensburg, Germany, with a clientele that includes the world’s leading pharmaceutical and biotechnology companies.
Dr. Feussner’s responsibilities encompass the divisions of Manufacturing Sciences & Process Development, Technology & Process Transfer, Project & Service Analytics, Drug Delivery Systems, as well as Product Development & Design. He joined Vetter in 2010 as Vice President, Quality Control.
Dr. Feussner was named to his current position in September 2014. Dr. Feussner began his career in 1997, and held a variety of positions of increasing importance at international pharmaceutical companies, including head of aseptic manufacturing, director of Quality Control, and Qualified Person. He holds a PhD in Natural Sciences from the Julius Maximilians University in Wurzburg, Germany. Dr. Feussner is a member of the German Pharmaceutical Society and the Parenteral Drug Association (PDA), as well as a member of the German and European QP association.
Company:Vetter
Headquartered in Ravensburg, Germany, Vetter is a family-owned, global leading contract development and manufacturing organization (CDMO) with production facilities in Germany, Austria and the United States. Currently employing more than 5,700 individuals worldwide, the company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small. Vetter services range from early stage development support including clinical manufacturing, to commercial supply and numerous packaging solutions for vials, syringes and cartridges. As a leading solution provider, Vetter appreciates its responsibility to support the needs of its customers by developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Great importance is also given to social responsibility including environmental protection and sustainability. Learn more about Vetter at www.vetter-pharma.com.
